辉瑞-BioNTech 已完成5到11岁儿童初步临床实验

美国制药公司辉瑞和德国生物科技公司BioNTech，已完成了他们针对5到11岁儿童的初步临床实验，并将会在接下来几个星期内，向美国监管机构，申请紧急授权使用。

辉瑞和BioNTech共同研发的2019冠状病毒疾病疫苗，已在超过两千两百多名5岁到11岁的儿童展开相关的初步临床实验。

如果获得紧急授权使用，5到11岁的相关幼童，最快可能在下个月底，就能接种辉瑞-BioNTech的冠病疫苗。

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s